Altshuler Shaham Ltd - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 303 filers reported holding HAEMONETICS CORP in Q1 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.

Quarter-by-quarter ownership
Altshuler Shaham Ltd ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q4 2022$57,100
-3.2%
726
-10.0%
0.00%
+100.0%
Q3 2022$59,000
+68.6%
807
+153.0%
0.00%
Q1 2021$35,000
+169.2%
319
+172.6%
0.00%
Q4 2019$13,000
+44.4%
117
+62.5%
0.00%
Q3 2019$9,000
+12.5%
72
-7.7%
0.00%
Q4 2018$8,000
+14.3%
78
+23.8%
0.00%
Q3 2018$7,000630.00%
Other shareholders
HAEMONETICS CORP shareholders Q1 2023
NameSharesValueWeighting ↓
Nitorum Capital, L.P. 413,122$16,608,0004.78%
Altalis Capital Management LLC 88,055$3,540,0003.97%
RUTABAGA CAPITAL MANAGEMENT LLC/MA 513,619$20,647,0003.54%
Black Creek Investment Management Inc. 1,118,613$44,968,0003.46%
HealthCor Management, L.P. 1,150,000$46,230,0002.61%
Van Berkom & Associates Inc. 1,136,971$45,706,0001.83%
AMERICAN CAPITAL MANAGEMENT INC 567,896$22,829,0001.77%
FULLER & THALER ASSET MANAGEMENT, INC. 2,062,539$82,914,0001.25%
Legato Capital Management LLC 1,336$53,707,0000.97%
HEARTLAND ADVISORS INC 351,314$14,123,0000.78%
View complete list of HAEMONETICS CORP shareholders